Stay updated on Pembrolizumab for Biliary Tract Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Biliary Tract Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Biliary Tract Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The site footer now shows revision v3.8.0 instead of v3.7.2, while the page remains a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T09:56:43.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    A site-wide banner announces updates about NIH website terminology, including the transition from “Artificial Intelligence” to “Super Intelligence.”
    Difference
    1%
    Check dated 2026-10-24T10:55:52.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The site revision identifier in the footer changes from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-17T12:22:31.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T12:30:56.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The page now renders a 403 Forbidden error, replacing the detailed study content with an access-denied message. The additions indicate a minimal HTML skeleton with a Home link and a revision note.
    Difference
    20%
    Check dated 2026-09-19T18:34:23.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    Revision updated from v3.6.5 to v3.6.6, indicating a backend update. No changes to the study details or page content.
    Difference
    0.1%
    Check dated 2026-08-29T20:55:29.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Biliary Tract Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Biliary Tract Cancer Clinical Trial page.